APA (7th ed.) Citation

U, K., JH, G., NGD, J., SM, A., M, J., SE, W., . . . MH, A. (2022). Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV. Frontiers in oncology, 12, 1023015. https://doi.org/10.3389/fonc.2022.1023015

Chicago Style (17th ed.) Citation

U, Klausen, et al. "Anti-PD-L1/PD-L2 Therapeutic Vaccination in Untreated Chronic Lymphocytic Leukemia Patients with Unmutated IgHV." Frontiers in Oncology 12 (2022): 1023015. https://doi.org/10.3389/fonc.2022.1023015.

MLA (9th ed.) Citation

U, Klausen, et al. "Anti-PD-L1/PD-L2 Therapeutic Vaccination in Untreated Chronic Lymphocytic Leukemia Patients with Unmutated IgHV." Frontiers in Oncology, vol. 12, 2022, p. 1023015, https://doi.org/10.3389/fonc.2022.1023015.